Alpine Immune Sciences to Report Third Quarter 2022 Financial Results
08 November 2022 - 8:30AM
Business Wire
Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading
clinical-stage immunotherapy company focused on developing
innovative treatments for autoimmune and inflammatory diseases,
today announced the company will release third quarter 2022
financial results on Monday, November 14, 2022, after the close of
market. The Company will host a corresponding conference call and
live webcast at 4:30 p.m. ET/1:30 p.m. PT on the same day.
Conference Call and Webcast Information
The link to the webcast will be available in the investor
relations section of the Company’s website at
https://ir.alpineimmunesciences.com/events and a replay will be
available on the Company's website for 90 days following the live
event.
About Alpine Immune Sciences
Alpine Immune Sciences is committed to leading a new wave of
immune therapeutics. With world-class research and development
capabilities, a highly productive scientific platform, and a proven
management team, Alpine is seeking to create first- or
best-in-class multifunctional immunotherapies via unique protein
engineering technologies to improve patients’ lives. Alpine has
entered into strategic collaborations with leading global
biopharmaceutical companies and has a diverse pipeline of clinical
and preclinical candidates in development. For more information,
visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on
Twitter and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221107006061/en/
Temre Johnson (Investors) Alpine Immune Sciences, Inc.
ir@alpineimmunesciences.com
Kelli Perkins (Media) Red House kelli@redhousecomms.com
Alpine Immune Sciences (NASDAQ:ALPN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alpine Immune Sciences (NASDAQ:ALPN)
Historical Stock Chart
From Apr 2023 to Apr 2024